Mindfulness-based Cognitive Therapy vs the Health Enhancement Program for Chronic Pain and Depression; The Quiet Focus Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-120
SponsorMassachusetts General Hospital

About this trial

The goal of this clinical trial is to pilot a randomized controlled trial comparing an adaptation of mindfulness-based cognitive therapy to the health enhancement program for chronic pain and depression. The main questions it aims to answer in a later fully powered randomized controlled trial are:

* Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life? * Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa

Pain in muscles, joints, bones, or associated soft tissues (NRS>4) lasting longer than 3 months

Depressed (PHQ-9 score of 5-14)

English fluency/literacy

Disqualifiers

Moderately severe or severe depressive symptoms (PHQ-9 ≥ 15)

Current substance abuse/dependence

Significant cognitive impairment

History of more than 8 sessions of cognitive-behavioral therapy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Quiet Focus

    Behavioral

    Mindfulness-based cognitive therapy adapted for older adults at-risk for chronic pain and depression

  • Health Enhancement Program

    Behavioral

    Time- and dose-matched control for Quiet Focus.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Quiet FocusExperimental treatment 1 intervention
Group B: Health Enhancement ProgramActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

The Credibility and Expectancy Questionnaire

This scale measures participant expectations around the study's positive outcomes, with measures ranging from 0 (not at all expected) to 9 (extremely expected). A higher score indicate greater trust in the study design and an openness to potential benefits.

Time frame
From enrollment to 3 months from the end of treatment at 8 weeks
2

The Client Satisfaction Questionnaire

Three item scale measuring patient satisfaction with the program. Scores for each item range from 1 (unsatisfied) to 4 (very satisfied).

Time frame
Administered at the end of treatment at 8 weeks and at the three month follow up visit
3

Modified Patient Global Impression of Change

Measures participant impressions of overall change with one being very much improved and eight being very much worse. Lower scores indicate improvement.

Time frame
At end of 8 week program (post test) and again at 3 month follow up visit

Secondary outcomes

1

Numerical Rating Scale

Numerical rating of pain with lower scores indicating less pain overall (0 = no pain) and higher scores indicating more pain (10 = worst ever pain) over the past week.

Time frame
From enrollment to 3 months from the end of treatment at 8 weeks
2

PROMIS Physical Function

The PROMIS Physical Function raw score is calculated by summing item responses, each rated on a 5-point Likert scale where 1 = "Unable to do" and 5 = "Without any difficulty," with higher scores indicating better function. This raw score is then converted to a T-score using a standardized table, where 50 represents the average in the general population and 10 is the standard deviation.

Time frame
From enrollment to 3 months from the end of treatment at 8 weeks
3

PROMIS Depression

The PROMIS Depression raw score is calculated by summing item responses, each rated on a 5-point Likert scale where 1 = "Never" and 5 = "Always," with higher scores indicating more severe depressive symptoms. This raw score is converted to a T-score using a standardized table, where 50 represents the average level in the general population and 10 is the standard deviation.

Time frame
From enrollment to 3 months from the end of treatment at 8 weeks
4

PROMIS Anxiety

The PROMIS Anxiety raw score is calculated by summing item responses, each rated on a 5-point Likert scale where 1 = "Never" and 5 = "Always," with higher scores reflecting greater anxiety symptoms. The raw score is then converted to a T-score using a standardized scoring table, with 50 representing the population average and 10 as the standard deviation.

Time frame
From enrollment to 3 months from the end of treatment at 8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Massachusetts General Hospital

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH)

Collaborator